Tom Bailey: I think in the fourth quarter, as I had mentioned in the prep remarks and in other comments, so we don’t put guidance at the bottom-end of the range for consumables, at what the Q3 pull-through was, at the top end of the range, you can assume about a 10% sequential improvement in pull-through, which is typically what we would see on a seasonal basis in a normal year. So, consistent with the comment that Brad just made about not assuming any improvement in the macro factors. That’s what that reflects. And so that’s where the overall guidance was built for Q4 and we’ll give more commentary on next year as we get into the February time frame, but the growth rate ranges that we assumed for the 40% to 50% range assumes the typical flat instrument year-over-year that we typically assume our nCounter guidance and pull-through that was consistent with what we observed this year, so no improvements next year.
So that still would suggest there would be some growth, but not any growth in the pull-through ranges that we experienced this year that were built in those preliminary assumptions.
Edmund Debler: Got it. And understanding you want to hold 2023 guidance until later, but how are you thinking about academic budgets heading into next year in-light of the upcoming returns in the U.S. and other government priorities such as energy subsidies in the EU?
Brad Gray: We have not in our commentary about next year’s growth rate factored any major changes then to academic research funding in one direction or the other. We’ll keep an eye on it, but you know, spatial biology is a relatively new field that I would hope would be funded pretty well. And you can see, I think that through some major recent initiatives, there’s a huge new brain mapping effort that’s underway, that’s being run out of the Allen Institute, up here in Seattle that represents a major application in spatial biology technology that’s just got, I think, $0.5 billion in research funding over multiple years ahead. So, my hope is, regardless of what the budget does overall, the application of new technologies like spatial will be at the top of the priority list.
Edmund Debler : Got it. Appreciate that. And one final question for me. Appreciating the fact that China is only about 5% of your total business, you’ve also talked about the fact that you wanted to expand your exposure in the region, so I was wondering if you think back about all of the headwinds that you saw during COVID and the ongoing headwinds in the region, has your international expansion plan in China or your approaches changed in any way? And do you plan on further expanding from that 10 plus direct sales in the region in the next 12 months?
Brad Gray: Our international expansion plans have not changed. Unfortunately, the investment we’ve made and the great team we’ve built in China haven’t really yet had a chance to prove what they can do because of the rolling lockdowns that we’ve experienced over there. But I still have high degree of confidence that they will succeed when provided €“ when things, kind of cool down with the virus and we don’t have any plans to reduce our pace of investment there.
Edmund Debler: Great. Thank you very much for the time.
Brad Gray: Thank you.
Operator: Thank you. There are currently no further questions registered. There are no additional questions waiting at this time.
Brad Gray: Very good. Thank you everyone for joining us today. A full transcript should be available, as well as a replay in the next couple of hours. You can access that by dialing 866-813-9403. The conference ID code 931170. Thank you again. This concludes our call.
Operator: That concludes the NanoString third quarter 2022 operating results conference call. Thank you for your participation. You may now disconnect your lines.
